Discontinuation report OXYTROL

Last updated on 2022-11-14 History
Report ID 172631
Drug Identification Number 02254735
Brand name OXYTROL
Common or Proper name OXYBUTYNIN TRANSDERMAL SYSTEM
Company Name ALLERGAN INC
Market Status MARKETED
Active Ingredient(s) OXYBUTYNIN
Strength(s) 3.9MG
Dosage form(s) PATCH
Route of administration TRANSDERMAL TRANSDERMAL
Packaging size 8s
ATC code G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-10-25
Actual discontinuation date 2022-10-25
Remaining supply date 2022-10-25
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2022-11-14 French Compare
v3 2022-11-14 English Compare
v2 2022-10-26 French Compare
v1 2022-10-26 English Compare

Showing 1 to 4 of 4